Loading company financials…
NEW YORK STOCK EXCHANGE, INC. · Real Estate · CIK 0000765880
$18.76
+1.96% · delayed ~15 min
Last price from Oct 20, 2026
$13.04B market value
From HEALTHPEAK PROPERTIES, INC.'s FY2025 10-K, filed Feb 3, 2026 · read the filing
HEALTHPEAK PROPERTIES owns income-producing property as a REIT. It took in $604.0M last year, which makes it a smaller company. Of every dollar it sells, about 12 cents is left as profit.
The financial picture is led by profitability, with growth and debt worth watching.
A conclusion from the filings, not a recommendation. Detailed figures and supporting evidence appear in their dedicated sections below.
Financial health
Generally healthy, with a few things to watch.
From HEALTHPEAK PROPERTIES, INC.'s FY2025 annual filing · share price scored separately
Largest year-over-year changes in FY2025
Profit
$243.1M → $71.3M
Profit margin
42.8% → 11.8%
Earnings per share
$0.35 → $0.10
Cash
$119.8M → $467.5M
Measured against FY2024, from the 10-K filed Feb 3, 2026
Deteriorated: -70.7%
$243.1M to $71.3MCritical
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
How the latest move compares (quote delayed ~15 min), and what was published around it
DOC rose 1.96% on the latest quote. The average Real Estate company tracked here moved +1.90%, and the S&P 500 −1.04%. That is in line with its sector and 3.0 points above the market.
These coincide with the move in time. None is presented as its cause: a price can move on news that names no company, on the wider market, or on trading that no document records.
Expectations
Not from the filings — what other people are betting on, and what the price already assumes.
Opinions from 26 analysts covering this company, as of . Their views, not this site's.
Of 26 analysts publishing on this company, 4 say strong buy, 6 say buy and 16 say hold. Analysts are paid to publish a view and are wrong often; the split above says how much they agree with each other, which is the part a single headline rating hides.
Published by Finnhub. Analyst coverage skews towards larger companies and towards optimism — sell ratings are rare across the whole market, so a company with none is ordinary rather than endorsed.
The essentials
Each answered from the filings, with the numbers behind it.
Yes. It keeps about 12 cents of every dollar of sales as profit, earning $71.3M last year.
Slowly. Sales grew 6.2% last year.
For every $1 it owes, it owns $1.69 in assets. Banks and insurers always carry high debt — that is how lending works — so this is normal for the industry and not comparable with other sectors.
Core operating and valuation reference metrics
Whether the dividend is covered by what the business actually earns
It pays out 1190% of its profit. Property trusts are required to distribute most of their income and report profit after heavy depreciation, so a figure above 100% is normal here rather than a warning. It paid out 68% of the cash its operations generated. It has paid in each of the last 12 years.
GoodNext payment expected around , projected from how regularly it has paid before rather than from a date the company has announced.
Figures from the FY2025 annual filing
Last year it earned $71.3M and generated $1.25B of cash from operations.
As reported to the SEC, in USD. Hover or show sources to see where each figure came from.
| Income statement | FY202510-K · Feb 3, 2026Filing for FY2025 | FY202410-K · Feb 4, 2025Filing for FY2024 | FY202310-K · Feb 9, 2024Filing for FY2023 | FY202210-K · Feb 8, 2023Filing for FY2022 | FY202110-K · Feb 9, 2022Filing for FY2021 | ChangeFY2025 vs FY2024 |
|---|---|---|---|---|---|---|
| RevenueWhat is this? | $604.0M | $568.5M | $527.4M | $494.9M | $471.3M | +6.2% |
| Cost of revenue | — | $1.07B | $902.1M | $863.0M | $773.3M | — |
| Gross profit | — | -$506.4M† | -$374.6M† | -$368.1M† | -$302.0M† | — |
| Gross marginGross profit ÷ revenueWhat is this? | — | -89.1% | -71.0% | -74.4% | -64.1% | — |
| Selling, general and administrative | $90.4M | $97.2M | $95.1M | $131.0M | $98.3M | −6.9% |
| Interest expense | $305.2M | $280.4M | $200.3M | $172.9M | $158.0M | +8.8% |
| Income before tax | $284.3M | $273.2M | $314.9M | $507.1M | $128.4M | +4.1% |
| Net income | $71.3M | $243.1M | $306.0M | $500.4M | $505.5M | −70.7% |
| Net marginNet income ÷ revenueWhat is this? | 11.8% | 42.8% | 58.0% | 101.1% | 107.3% | −31.0 pts |
| Earnings per shareNet income ÷ shares outstanding at the period end — close to, but not the same as, the reported EPSWhat is this? | $0.1027 | $0.3476 | $0.5593 | $0.9155 | $0.9378 | −70.5% |
† calculated from other reported figures, such as total liabilities as assets minus equity.
This company's latest filing beside its peers' stored scores
| Company | Health | F-Score | Revenue growth | Profit margin | P/E | Debt to equity |
|---|---|---|---|---|---|---|
| DOCHEALTHPEAK PROPERTIES, INC. · this page | 7.3/10 | 5/7 |
Insider activity, ownership stakes and what's coming — straight from EDGAR, before any article is written about it
Estimated from how often this has happened before, not a confirmed date.
Not investment advice, and not a signal to act on by itself — a filing says what happened, not why, and insiders trade for ordinary reasons having nothing to do with where they think the company is headed.
20 recent filings, newest first. Each is labelled from its form and item numbers, not from its wording.
Quarterly report for Q2 FY2026
Revenue +45.4% · Profit margin +3.1 pts · Profit +66.8% — against Q2 FY2025
Read the filingPublished results · Made a Regulation FD disclosure
Read the filingWrite down why you are following HEALTHPEAK PROPERTIES, INC., what has to go right and what would change your mind, then see each new annual report measured against it. Sign in to start one.
Go deeper
Every figure above traces back to a filing in the timeline, each linked to the document itself.
The 1,324 subsidiaries named in its 10-K, incorporated across 21 places. A filer lists the significant ones and may leave the rest out, so this is the floor rather than the full count.
Every company's figures are checked for internal consistency: the balance sheet adding up, figures sharing one currency, cash flow and share counts within plausible ranges, and how recent the latest annual report is. Nothing here changes a figure.
Financial figures are from DOC's 10-K for fiscal year 2025 (period ending 2025-12-31, filed Feb 3, 2026), reported under the US GAAP taxonomy. View the source filing.
3 of 4 scored areas had enough reported figures to judge
The score averages profitability, growth, debt and accounting. Accounting had too few reported figures and is left out of the average rather than counted as a weakness, so a company is never marked down for a figure it did not publish. Cash generation is shown for context and already feeds profitability. Valuation is scored separately, because a share price says nothing about whether the business is sound. 7 of the 9 Piotroski checks could be evaluated. How the score works
Each year scored only from its annual report as it was first filed
| Fiscal year | Health | F-Score | Scored from |
|---|---|---|---|
| FY2025 | 7.3 | 5/7 | 10-K, filed Feb 3, 2026 |
| FY2024 | 7.3 | 4/8 | 10-K, filed Feb 4, 2025 |
| FY2023 | 7.3 | 6/8 | 10-K, filed Feb 9, 2024 |
| FY2022 | 6.0 | 5/8 | 10-K, filed Feb 8, 2023 |
| FY2021 | 7.3 | 8/8 | 10-K, filed Feb 9, 2022 |
| FY2020 | 7.3 | 7/8 | 10-K, filed Feb 10, 2021 |
A later restatement never reaches back into an earlier year, and every year is scored without a share price, so the latest point can differ a little from the headline score, which uses today's price.
Every check behind the three models, and what each one tests
5 of 7 checks passed
Nine yes-or-no tests of whether this year's finances improved on last year's. 2 could not be evaluated and are excluded from the total rather than counted as failures.
not reported — Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Distance from bankruptcy, from a model fitted on companies that did and did not go bust. It describes a balance sheet's shape today; it does not forecast a failure.
not reported — Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Screens eight accounting ratios for the pattern earnings manipulators tend to leave. A flag is a reason to read the filing closely, never evidence of wrongdoing.
Every figure above comes from the FY2025 filing as filed with the SEC.
Deteriorated: −31.0 pts
42.8% to 11.8%Critical
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Deteriorated: -70.5%
$0.35 to $0.10Critical
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Improved: +290.1%
$119.8M to $467.5MCritical
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Changed: +21.5%
$736.8M to $894.9MSignificant
Why it matters: Neither good nor bad on its own. Heavy spending is a company building capacity or a company struggling to stand still, and the two look identical in this figure.
Improved: +6.2%
$568.5M to $604.0MNotable
Why it matters: Sales are what everything else is built on. A fall can be lost customers, lower prices, or a business the company sold — the filing itself says which.
Improved: +7.0%
$333.7M to $357.0MNotable
Why it matters: Cash left after paying for the plant that produced it — the money genuinely available for dividends, buybacks or paying down debt. Harder to flatter than profit.
Deteriorated: +13.0%
$8.72B to $9.85BNotable
Why it matters: Rising debt is not automatically bad — borrowing to build something that earns more than the interest is ordinary. It matters when it grows faster than the profit meant to service it.
Changed: +6.8%
$794.8M to $849.1MNotable
Why it matters: Cash handed to shareholders. A rise can be a higher dividend or simply more shares, and a cut is a decision the company explains in its own filing — neither is rated here.
Q2 FY2026 against Q2 FY2025, from the 10-Q filed Aug 5, 2026 — read it.
Improved: +45.4%
$148.9M to $216.5MCritical
Why it matters: Sales are what everything else is built on. A fall can be lost customers, lower prices, or a business the company sold — the filing itself says which.
Improved: +66.8%
$31.7M to $52.8MCritical
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Improved: +68.1%
$0.05 to $0.08Critical
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Improved: +1719.0%
$89.4M to $1.63BCritical
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Improved: +3.1 pts
21.3% to 24.4%Significant
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Deteriorated: +11.0%
$9.04B to $10.03BNotable
Why it matters: Rising debt is not automatically bad — borrowing to build something that earns more than the interest is ordinary. It matters when it grows faster than the profit meant to service it.
Q2 FY2026 against Q1 FY2026, from the 10-Q filed Aug 5, 2026 — read it. Quarter-to-quarter moves include seasonal swings — a retailer's holiday quarter — which the year-earlier comparison removes.
Deteriorated: -72.7%
$193.6M to $52.8MCritical
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Deteriorated: −72.3 pts
96.6% to 24.4%Critical
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Deteriorated: -72.5%
$0.28 to $0.08Critical
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Improved: +38.9%
$1.17B to $1.63BSignificant
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Improved: +8.0%
$200.3M to $216.5MNotable
Why it matters: Sales are what everything else is built on. A fall can be lost customers, lower prices, or a business the company sold — the filing itself says which.
1 other measure barely moved. Figures compare the two most recent annual filings — read the latest one. Moves are graded on fixed lines — 5%, 15% and 40% for amounts, and 1, 3 and 8 points for margins — as notable, significant or critical. Nothing here reads the management commentary, which is where a company explains its own numbers.
Filter by minute, hour, day or week — or compare against peers
Loading price history…
Measured on and published about a week later — this is a fortnightly snapshot, not a live position.
About 3.4% of this company's shares have been borrowed and sold by people expecting to buy them back cheaper. That is a bet the price falls. Those people can be wrong, and when a heavily shorted share rises they have to buy it back, which pushes it up further.
Collected by FINRA from broker-dealers twice a month. It counts positions, not intentions, and some of it is hedging rather than a directional bet against the company.
Nothing in this section is a figure this company reported about itself. These are expectations and positions — what the price implies, what analysts have published, what short sellers are betting, and what large funds held at the last count. WylthIQ reports them; it does not endorse them, does not forecast prices, and takes no view on whether any of them will turn out to be right.
The trailing P/E is 81.0x — a high multiple relative to the current trailing profit.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Reported annual figures
| 6.2% |
| 11.8% |
| 182.75x |
| 1.60x |
| WELLWELLTOWER INC. | 8.7/10 | 6/8 | 40.2% | 11.4% | 171.91x | 0.57x |
|---|
| AREALEXANDRIA REAL ESTATE EQUITIES, INC. | 3.3/10 | 4/7 | -2.9% | -47.2% | — | 0.96x |
|---|
| Median of peers | 6.0/10 | — | 18.7% | -17.9% | 171.91x | 0.77x |
|---|
Peers come from the company's industry classification. A difference describes the companies; it does not rank them.
Quarterly report for Q1 FY2026
Revenue +34.5% · Profit margin +67.9 pts · Profit +352.1% — against Q1 FY2025
Published results · Made a Regulation FD disclosure
Read the filingHeld a shareholder vote
Read the filingSigned a material agreement · Took on a direct financial obligation
Read the filingProxy statement for a shareholder meeting
Read the filingMade a Regulation FD disclosure
Read the filingAnnual report for FY2025
Revenue +6.2% · Profit margin −31.0 pts · Profit -70.7% — against FY2024
Read the filingPublished results · Made a Regulation FD disclosure
Read the filingQuarterly report for Q3 FY2025
Revenue +5.3% · Profit margin −138.0 pts · Profit turned negative — against Q3 FY2024
Read the filingPublished results · Made a Regulation FD disclosure
Read the filingReported another event
Read the filingReported another event
Read the filingReported another event
Read the filingQuarterly report for Q2 FY2025
Revenue +5.7% · Profit margin −82.4 pts · Profit -78.3% — against Q2 FY2024
Read the filingPublished results · Made a Regulation FD disclosure
Read the filingMade a Regulation FD disclosure
Read the filingHad a director or senior officer leave or join · Held a shareholder vote
Read the filingQuarterly report for Q1 FY2025
Revenue +7.3% · Profit margin +23.9 pts · Profit +541.5% — against Q1 FY2024
Read the filingThe first 40 of 1,324. The rest are in the exhibit.
Source: Exhibit 21 of the 10-K filed 2026-02-03. These are legal entities, not brands or acquisitions — a company that bought a business may hold it inside an entity named here, or inside one small enough that the rule does not require naming it at all.
Coverage from the last 30 days
What To Watch This REIT Earnings Season
SeekingAlpha ·
S&P 500 Top Movers: Oct. 19, 2026 US Session Gainers and Losers
ChartMill ·
Wells Fargo Maintains Equal-Weight on Healthpeak Properties, Lowers Price Target to $19
Benzinga ·
Better High-Yield Dividend Stock: Pfizer vs. Healthpeak
Yahoo ·
Better High-Yield Dividend Stock: Realty Income vs. Healthpeak
Yahoo ·
UBS Maintains Neutral on Healthpeak Properties, Lowers Price Target to $20
Benzinga ·
Barclays Maintains Equal-Weight on Healthpeak Properties, Lowers Price Target to $21
Benzinga ·
Healthpeak Properties (DOC) Reaffirmed Its Dividend, Is It Still Below Fair Value?
Yahoo ·
Did Healthpeak’s (DOC) Steady 2026 Payout and Higher FFO Guidance Quietly Redefine Its Capital Priorities?
Yahoo ·
Healthpeak Properties (DOC) Stock Still Looks Cheap Following Its 31% Run
Yahoo ·
Better High-Yield Dividend Stock: Crown Castle vs. Healthpeak
Yahoo ·
Better High-Yield Dividend Stock: VICI Properties vs. Healthpeak
Yahoo ·
Primary sources and further research